• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核再治疗结果及相关因素:一项来自印度本地治里的混合方法研究。

Tuberculosis retreatment outcomes and associated factors: a mixed-methods study from Puducherry, India.

作者信息

Velavan A, Purty A J, Shringarpure K, Sagili K D, Mishra A K, Selvaraj K S, Manikandan M, Saravanan V

机构信息

Department of Community Medicine, Pondicherry Institute of Medical Science (PIMS), Puducherry, India.

National Task Force, Revised National Tuberculosis Control Programme, New Delhi, India.

出版信息

Public Health Action. 2018 Dec 21;8(4):187-193. doi: 10.5588/pha.18.0038.

DOI:10.5588/pha.18.0038
PMID:30775279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6361493/
Abstract

Four Tuberculosis (TB) Units in the Union Territory of Puducherry in India. To identify factors associated with unfavourable outcomes among retreatment TB cases in Puducherry. The study had a mixed-methods design in which routinely reported TB data from retreatment TB cases registered during 2014 and 2015 were used for the quantitative part; the qualitative phase comprised interviews and focus group discussions with health care providers. Among the 392 retreatment cases, 297 (75.8%) had favourable outcomes. Outcome for previous treatment such as loss to follow-up (LTFU) (adjusted relative risk [aRR] 1.6, 95%CI 1.1-2.4, = 0.001), treatment failure (aRR 1.7, 95%CI 1.04-2.8, = 0.03) and pre-treatment weight <40 kg (aRR 1.8, 95%CI 1.3-2.5, = 0.001) had increased risk for unfavourable outcomes. Health care providers reported that alcoholism, lack of family support, job-related issues and lack of access to trained staff for injections were some of the reasons for unfavourable outcomes. Providing incentives, nutritional supplements and early retrieval of the LTFU cases were some of the suggestions to reduce unfavourable outcomes. Outcome of previous treatment and low pre-treatment weight of the patient affected retreatment outcomes. Health professionals and workers highlighted social and health system-related factors. Commitment at all levels on the part of health care providers and addressing their concerns can improve retreatment outcomes.

摘要

印度本地治里中央直辖区的四个结核病防治单位。旨在确定本地治里复治结核病病例中与不良结局相关的因素。该研究采用混合方法设计,其中2014年和2015年登记的复治结核病病例的常规报告结核病数据用于定量部分;定性阶段包括对医疗服务提供者的访谈和焦点小组讨论。在392例复治病例中,297例(75.8%)预后良好。既往治疗结局如失访(调整相对风险[aRR]1.6,95%可信区间1.1 - 2.4,P = 0.001)、治疗失败(aRR 1.7,95%可信区间1.04 - 2.8,P = 0.03)以及治疗前体重<40 kg(aRR 1.8,95%可信区间1.3 - 2.5,P = 0.001)的患者出现不良结局的风险增加。医疗服务提供者报告称,酗酒、缺乏家庭支持、工作相关问题以及缺乏接受过注射培训的工作人员是导致不良结局的部分原因。提供激励措施、营养补充剂以及早期找回失访病例是减少不良结局的一些建议。既往治疗结局和患者治疗前低体重影响复治结局。卫生专业人员和工作者强调了社会和卫生系统相关因素。医疗服务提供者在各级的承诺以及解决他们的担忧可以改善复治结局。

相似文献

1
Tuberculosis retreatment outcomes and associated factors: a mixed-methods study from Puducherry, India.肺结核再治疗结果及相关因素:一项来自印度本地治里的混合方法研究。
Public Health Action. 2018 Dec 21;8(4):187-193. doi: 10.5588/pha.18.0038.
2
Is a differentiated care model needed for patients with TB? A cohort analysis of risk factors contributing to unfavourable outcomes among TB patients in two states in South India.对于结核病患者来说,是否需要采用差异化的护理模式?对印度南部两个邦的结核病患者不良结局相关因素的队列分析。
BMC Public Health. 2020 Jul 24;20(1):1158. doi: 10.1186/s12889-020-09257-5.
3
Public-private mix for tuberculosis care and control in Myanmar: a strategy to scale up?缅甸结核病防治公私合作模式:扩大规模的策略?
Public Health Action. 2017 Mar 21;7(1):15-20. doi: 10.5588/pha.16.0103.
4
"Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.“宁愿死也不吃这些药”:一项基于社区的关于印度哈里亚纳邦法里达巴德地区结核病患者治疗失访决定因素的定性研究。
Cureus. 2022 May 15;14(5):e25030. doi: 10.7759/cureus.25030. eCollection 2022 May.
5
Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.在印度卡纳塔克邦,使用具有创新性的依从性支持工具的每日治疗方案治疗感染艾滋病毒的结核病患者的结果和实施挑战:一项混合方法研究。
Glob Health Action. 2019;12(1):1568826. doi: 10.1080/16549716.2019.1568826.
6
Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis.治疗依从性对印度本地治里结核病患者性别与不良治疗结局之间关联的影响:中介分析。
J Public Health (Oxf). 2023 Jun 14;45(2):304-311. doi: 10.1093/pubmed/fdac062.
7
Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.津巴布韦耐多药和利福平耐药结核病的治疗结果:2010 年至 2015 年期间开始治疗的患者队列分析。
PLoS One. 2020 Apr 30;15(4):e0230848. doi: 10.1371/journal.pone.0230848. eCollection 2020.
8
Predictors of unfavourable treatment outcome in patients with multidrug-resistant tuberculosis in India.印度耐多药结核病患者不良治疗结局的预测因素
Public Health Action. 2017 Mar 21;7(1):32-38. doi: 10.5588/pha.16.0055.
9
Tuberculosis treatment outcomes among disadvantaged patients in India.印度弱势患者的结核病治疗结果。
Public Health Action. 2017 Jun 21;7(2):134-140. doi: 10.5588/pha.16.0107.
10
High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.2012 - 2014年缅甸耐多药结核病患者的高治疗成功率:一项回顾性队列研究
Trans R Soc Trop Med Hyg. 2017 Sep 1;111(9):410-417. doi: 10.1093/trstmh/trx074.

引用本文的文献

1
Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.印度结核病防治护理链参与障碍的系统评价:定量研究。
PLoS Med. 2024 May 28;21(5):e1004409. doi: 10.1371/journal.pmed.1004409. eCollection 2024 May.
2
Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research.印度次大陆结核病治疗中的患者依从性:定性研究的系统评价和荟萃分析。
BMJ Open. 2023 May 4;13(5):e063926. doi: 10.1136/bmjopen-2022-063926.
3
Why and where?-Delay in Tuberculosis care cascade: A cross-sectional assessment in two Indian states, Jharkhand, Gujarat.为何及何处发生?-结核病关怀链中的延误:在印度两个邦(恰尔康得邦、古吉拉特邦)进行的横断面评估。
Front Public Health. 2023 Jan 27;11:1015024. doi: 10.3389/fpubh.2023.1015024. eCollection 2023.
4
Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India.印度南部耐多药肺结核患者在结核病强化治疗期间体重减轻的预测因素。
J Public Health (Oxf). 2023 Aug 28;45(3):545-552. doi: 10.1093/pubmed/fdac141.
5
"Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.“宁愿死也不吃这些药”:一项基于社区的关于印度哈里亚纳邦法里达巴德地区结核病患者治疗失访决定因素的定性研究。
Cureus. 2022 May 15;14(5):e25030. doi: 10.7759/cureus.25030. eCollection 2022 May.
6
Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia.合并精神分裂症的结核病患者入院时再次治疗的危险因素。
Front Psychiatry. 2021 Dec 9;12:793470. doi: 10.3389/fpsyt.2021.793470. eCollection 2021.
7
Contributing Factors in the Tuberculosis Care Cascade in India: A Systematic Literature Review.印度结核病治疗流程中的影响因素:一项系统文献综述
Risk Manag Healthc Policy. 2021 Aug 10;14:3275-3286. doi: 10.2147/RMHP.S322143. eCollection 2021.

本文引用的文献

1
Human genetic factors in tuberculosis: an update.结核病中的人类遗传因素:最新进展
Trop Med Int Health. 2017 Sep;22(9):1063-1071. doi: 10.1111/tmi.12923. Epub 2017 Jul 19.
2
"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention.“当治疗比疾病更具挑战性时”:耐多药结核病患者留存率的定性研究
PLoS One. 2016 Mar 9;11(3):e0150849. doi: 10.1371/journal.pone.0150849. eCollection 2016.
3
Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda.乌干达三家地区医院结核病复治病例的特征及治疗结果
Public Health Action. 2013 Jun 21;3(2):149-55. doi: 10.5588/pha.12.0105.
4
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.乌兹别克斯坦新患结核病患者和既往治疗过的结核病患者治疗效果不佳的相关因素:一项为期五年的全国性研究。
PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.
5
Treatment outcomes among new smear positive and retreatment cases of tuberculosis in Mangalore, South India - a descriptive study.印度南部芒格洛尔新涂片阳性和复治肺结核病例的治疗结果——一项描述性研究。
Australas Med J. 2011;4(4):162-7. doi: 10.4066/AMJ.2011.585. Epub 2011 Apr 30.
6
Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006.印度再治疗结核病患者治疗中断的危险因素,2006 年。
PLoS One. 2010 Jan 25;5(1):e8873. doi: 10.1371/journal.pone.0008873.
7
Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines.报告标准:CONSORT、QUORUM和STROBE指南。
Clin Orthop Relat Res. 2009 Jun;467(6):1393-4. doi: 10.1007/s11999-009-0786-x. Epub 2009 Mar 19.
8
Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.印度西孟加拉邦农村地区国家结核病控制规划下涂片阳性复治患者不同亚组的治疗结果。
Rural Remote Health. 2009 Jan-Mar;9(1):926. Epub 2009 Feb 27.
9
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.定性研究报告的统一标准(COREQ):访谈和焦点小组的32项清单
Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.
10
The effects of increasing incentives on adherence to tuberculosis directly observed therapy.增加激励措施对结核病直接观察治疗依从性的影响。
Int J Tuberc Lung Dis. 2000 Sep;4(9):860-5.